Skip to main content

Ua pilikia anei kou ʻike ma muli o ka maʻi diabetes? E kamaʻilio kākou e pili ana i ka lāʻau lapaʻau ʻo Vabysmo (Faricimab)

Ua pilikia anei kou ʻike ma muli o ka maʻi diabetes? E kamaʻilio kākou e pili ana i ka lāʻau lapaʻau ʻo Vabysmo (Faricimab)

Inā loaʻa iā ʻoe ka maʻi diabetes, ʻike paha ʻoe i ka hala ʻana o ka manawa, hiki ke hoʻopilikia i kou mau maka. ʻO ka ʻike maka pohihihi, nā mea lana, a me ka makapō kala nā hōʻailona maʻamau o kēia ʻano. Ua lohe paha ʻoe i nā inikini maka ma ke ʻano he lāʻau lapaʻau no kēia ʻano. Hiki i kēia mau inikini ke hoʻomaikaʻi i ka ʻike a hoʻōki i ka hōʻino hou ʻana i kou mau maka. I kēia lā, e kamaʻilio mākou e pili ana i kekahi lāʻau lapaʻau hou, kahi mea e kōkua nui iā ʻoe.

Pehea ka hana a kēia lāʻau Vabysmo no nā maka?

I ka ʻōlelo maʻalahi, ke loaʻa i kahi kanaka me ka maʻi diabetes ke kiʻekiʻe o ke kō koko no ka manawa lōʻihi, hoʻomaka ka hōʻino ʻia ʻana o nā kīʻaha koko palupalu i loko o ka maka. Hana ʻia kēia hōʻino ma ka retina, ka papa o ka maka e hana i nā kiʻi. Kāhea mākou i kēia ʻano he diabetic retinopathy .

Hoʻokahe mālie kēia mau kīʻaha koko i hōʻino ʻia i ke koko a me ka wai i loko o ka retina. I ka wā e ʻoi aʻe ai ke kūlana, hoʻāʻo ka maka e hana i nā kīʻaha koko hou e pani i nā mea i hōʻino ʻia. Akā, ua nāwaliwali loa kēia mau kīʻaha koko hou, a ʻoi aku ka nui o ka wai e kahe ana.

No laila he aha ka macular edema?

Aia kekahi wahi kūikawā ma ka retina i kapa ʻia ʻo ka macula . ʻO kēia ka mea e kōkua iā mākou e ʻike i nā mea i mua o ko mākou mau maka, ʻo ia hoʻi, ko mākou ʻike pololei, me ka maopopo. E like me ka mea i ʻōlelo ʻia ma mua, i ka wā e kahe ai ke wai mai nā kīʻaha koko, hoʻomaka kēia macula e pehu. Kāhea mākou i kēia he edema macular diabetic .

ʻO kēia ka manawa e pōwehiwehi ai ka ʻike, ʻike pālua ʻia ka ʻike, ʻike ʻia nā kiko ʻeleʻele, a ʻike ʻia nā kala me ka palalulu. Hiki i kekahi poʻe ke nalowale loa ko lākou ʻike.

He aha ka mea kūikawā e pili ana iā Vabysmo?

ʻO ka pahuhopu nui o ka mālama ʻana i kēia kūlana, ʻo ia ke kāohi i ka hōʻino ʻana i ka retina. Aia kekahi mau ʻano lāʻau lapaʻau i hoʻokomo ʻia i loko o ka maka no kēia. Hana ka hapa nui o kēia mau lāʻau lapaʻau ma ke kāohi ʻana i kahi protein i kapa ʻia ʻo VEGF . I ka ʻōlelo maʻalahi, ʻo VEGF kahi mea nui e kōkua ai i kēlā mau kīʻaha koko hou i makemake ʻole ʻia a nāwaliwali hoʻi e hana. No laila, ke ālai ʻia ʻo VEGF, ua kāohi ʻia ke kūkulu ʻia ʻana o nā kīʻaha koko hou.

ʻO Faricimab ka mea hana nui i loko o Vabysmo. ʻO kēia lāʻau lapaʻau, e like me nā lāʻau lapaʻau ʻē aʻe, ke ālai nei i ka VEGF. Akā ma waho aʻe o kēlā, hana kēia lāʻau lapaʻau i kahi mea ʻē aʻe. ʻO ia hoʻi, ke ālai nei ia i kahi protein ʻē aʻe i kapa ʻia ʻo Ang-2 (angiopoietin-2) . Ke hoʻonui ʻia kēia protein Ang-2 i loko o ka maka, lilo nā kīʻaha koko i mea paʻa ʻole a kahe hou aku ka wai.

No laila, no ka mea, ke ālai nei ʻo Vabysmo iā VEGF a me Ang-2 i ka manawa like, ke kāohi nei ia i ke kūkulu ʻia ʻana o nā kīʻaha koko hou a hoʻopaʻa i nā kīʻaha koko e kū nei, e hōʻemi ana i ka liki ʻana o ka wai. ʻO kēia hana pālua ka mea e kū hoʻokahi ai ʻo Vabysmo.

He aha ka mea i hōʻike ʻia e ka noiʻi ʻana e pili ana i kēia lāʻau lapaʻau?

Ua mālama ʻia ʻelua mau hoʻokolohua lapaʻau nui e hoʻoholo ai i ka palekana a me ka pono o Vabysmo, e pili ana i kahi heluna nui o ka poʻe me ka maʻi diabetes a me ka macular degeneration mai nā ʻāina a me nā lāhui like ʻole a puni ka honua.

Ma kēia mau hoʻokolohua, ua hoʻohālikelike ʻia ʻo Vabysmo me kahi lāʻau i loaʻa mua i kapa ʻia ʻo Aflibercept (Eylea) , ka mea e ālai wale ana i ka VEGF. ʻAʻole ʻike ka poʻe i komo i ka hoʻokolohua i ka lāʻau a lākou e loaʻa nei. Ua loaʻa i nā kānaka a pau kekahi mau inikini, akā ua emi iho ka nui o nā inikini i loaʻa i kekahi poʻe ma mua o nā poʻe ʻē aʻe.

He aha nā hopena o ka noiʻi?

He mea hoʻoikaika maoli nā hopena.

Ka hoʻomaikaʻi ʻana i ka ʻike maka

Ma hope o hoʻokahi makahiki o ka lāʻau lapaʻau, ua hoʻomaikaʻi nui ʻia ka ʻike o ka poʻe i lawe iā Vabysmo lāua ʻo Aflibercept ma mua o ka wā i hoʻomaka ai ke aʻo ʻana. ʻO ke ʻano kēia ua like ka maikaʻi o nā lāʻau ʻelua i ka hoʻomaikaʻi ʻana i ka ʻike .

Ka nui o nā inikini i koi ʻia (ʻo ia ka mea nui loa!)

ʻO kēia kahi i ʻike ʻia ai ka ʻokoʻa nui loa.

I nā mahina mua o ka noiʻi, ua hoʻopili ʻia nā kānaka a pau i hoʻokahi manawa i ka mahina, akā ua hoʻololi ʻia ka papa hana hoʻopili.

  • Ua hoʻomau ka poʻe i loaʻa iā Aflibercept i ka loaʻa ʻana o ka lāʻau pale i kēlā me kēia 8 pule (ʻo ia hoʻi, i kēlā me kēia 2 mahina) ma hope o nā mahina 5 mua.
  • Ua mālama ʻia ka poʻe i loaʻa iā Vabysmo e like me kahi "papa kuhikuhi dosis pilikino," ʻo ia hoʻi, ua loiloi ʻia ke kūlana o ka maka o kēlā me kēia kanaka a ua hāʻawi ʻia ka lāʻau pale i kēlā me kēia 4, 8, 12, a i ʻole 16 pule, e like me ke kūpono.

Ua hōʻike ʻia nā hopena he ʻoi aku ma mua o 70% o ka poʻe i loaʻa iā Vabysmo he pana wale nō i pono i kēlā me kēia 12-16 pule (ʻo ia hoʻi, i kēlā me kēia 3-4 mahina) . Eia kekahi, ʻaʻohe ʻokoʻa i ka hoʻomaikaʻi ʻana o ka maka ma waena o ka poʻe i loaʻa i ka lāʻau i kēlā me kēia 3-4 mahina a me ka poʻe i loaʻa i ka lāʻau i kēlā me kēia 2 mahina.

ʻO ke ʻano kēia, hiki i ka lāʻau lapaʻau ʻo Vabysmo ke hōʻemi nui i ka nui o nā kipa ʻana i ka haukapila no nā inikini , me ka mālama ʻana i ka hoʻomaikaʻi ʻana o ka ʻike. He mea maʻalahi loa ka hele ʻole ʻana i ka haukapila pinepine, ʻeā?

LapaʻauKa Wā Hoʻokomo Maʻamau
ʻO Vabysmo (Faricimab) 12 a 16 mau pule (i kēlā me kēia 3-4 mahina)
ʻAflibercept (Eylea) Hoʻokahi i kēlā me kēia 8 pule (hoʻokahi i kēlā me kēia 2 mahina)

E hoʻomau anei ka hana a ka lāʻau lapaʻau ma hope o ka makahiki mua?

ʻAe. Ua mālama ʻia kēia noiʻi ma luna o ʻelua mau makahiki. ʻO ka mea a lākou i ʻike ai, ma hope o ʻelua mau makahiki, ma kahi o 78% o ka poʻe i lawe iā Vabysmo e pono ai ka lāʻau lapaʻau i kēlā me kēia 3-4 mahina . A ua mau ko lākou ʻike e like me ia i ka makahiki mua.

Ma muli o ka holomua ʻana o ka pōʻino o ka maka mai ka maʻi diabetes i ka hala ʻana o ka manawa, hōʻike kēia mau hopena e hiki iā Vabysmo lāua ʻo Aflibercept ke kōkua i ka pale ʻana i ka pōʻino lōʻihi o ka maka. Hiki nō hoʻi iā Vabysmo ke hoʻokō i kēia hopena me nā lāʻau lapaʻau liʻiliʻi.

Pehea e loaʻa ai kēia lāʻau lapaʻau?

He wai ʻo Vabysmo. He inikini intravitreal ia i hāʻawi pololei ʻia i loko o ka maka e ke kauka i aʻo ʻia . ʻAʻole hiki iā ʻoe ke hana i kēia ma ka home.

Ke hoʻomaka ʻoe i ka lāʻau lapaʻau, e loaʻa mua iā ʻoe he 4 mau inikini i kēlā me kēia 4 pule . A laila e nānā kāu kauka i kou mau maka a hoʻoholo inā e hoʻomau i nā inikini ma nā manawa 4, 8, 12, a i ʻole 16 pule, ma muli o ke kūlana o kou mau maka. ʻO ka hapa nui o ka poʻe e pono ai nā inikini i kēlā me kēia 3-4 mahina.

I ka wā o ka inikini, e hoʻohana ke kauka i kahi mea liʻiliʻi e paʻa ai kou maka. A laila, e kau lākou i nā kulu i loko o kou maka e hoʻomāʻū iā ia a pale i ka maʻi. A laila, hāʻawi ʻia ka inikini me kahi nila lahilahi loa. ʻAʻole ʻoe e ʻeha i kēia manawa.

Nā hopena ʻaoʻao a pehea e mālama ai iā lākou?

E like me nā lāʻau lapaʻau āpau, hiki i kēia ke loaʻa nā hopena ʻaoʻao liʻiliʻi.

  • Nā hopena ʻaoʻao maʻamau: Hiki ke pohihihi kou ʻike no kekahi manawa pōkole ma hope o ka inikini. He mea maʻamau kēia. E pale i ka hoʻokele kaʻa a i ʻole ka hoʻohana ʻana i nā mīkini i kēia manawa. E hoʻi hou kou ʻike i ka maʻamau i ka manawa pōkole.
  • Nā hōʻailona koʻikoʻi e makaʻala ai: He mea kākaʻikahi loa, hiki ke loaʻa nā hōʻailona o kekahi mau maʻi koʻikoʻi. Pono ʻoe e makaʻala i kēia mau mea.
  • Me he mea lā e lana ana nā kiko ʻeleʻele a i ʻole nā ​​kaha i mua o nā maka.
  • Nā ʻālohilohi o ke kukui e like me ka uila .
  • Me he mea lā e huki ʻia ana kahi pale i mua o nā maka.
  • ʻEha nui o ka maka .

Inā ʻike ʻoe i kekahi o kēia mau hōʻailona, ​​mai hoʻokaʻulua . E ʻimi koke i ke kōkua lapaʻau. Inā hiki, e hele i ka ETU (Emergency Treatment Unit) o ​​ka haukapila no ka mālama ʻana. He mau hōʻailona paha kēia o kahi maʻi koʻikoʻi.

Aia kekahi pilikia me nā lāʻau lapaʻau ʻē aʻe?

ʻAʻohe pilina i ʻike ʻia ma waena o Vabysmo a me nā lāʻau lapaʻau ʻē aʻe i kēia manawa.

Akā, he mea nui loa kēia: E hōʻoia e haʻi i kāu kauka e pili ana i nā lāʻau lapaʻau ʻē aʻe āu e lawe nei, me nā lāʻau lapaʻau i kauoha ʻia, nā huaora, nā huahana lāʻau, a me nā lāʻau lapaʻau kuʻuna.

Leka Lawe-Home

  • He lāʻau pale hou ʻo Vabysmo, hana pālua ia e mālama ai i ka diabetic macular edema (DME).
  • Hoʻopale kēia i ʻelua mau protein (VEGF a me Ang-2) e kaohi ana i ke kūkulu ʻia ʻana o nā kīʻaha koko hou a me ke kahe ʻana o ka wai.
  • ʻAe kēia i nā poʻe he nui e hōʻemi i ke alapine (frequency) o nā lāʻau pale i kēlā me kēia 3-4 mahina me ka mālama ʻana i ka hoʻomaikaʻi like ʻana o ka maka.
  • He iniki kēia i hāʻawi ʻia i ka maka e ke kauka, a he mea nui loa ka loaʻa ʻana o ka lāʻau lapaʻau i ka manawa kūpono.
  • Inā loaʻa iā ʻoe ka ʻeha nui o ka maka, nā ʻālohilohi o ke kukui, a i ʻole ka uhi ʻana o kou maka e like me ka pale ma hope o ka loaʻa ʻana o ka lāʻau lapaʻau, e ʻimi koke i ke kōkua lapaʻau.
  • E kūkākūkā mau me kāu kauka maka i ke ʻano o ka lāʻau lapaʻau kūpono loa no kou kūlana.

Maʻi diabetes, ʻIke maka, Vabysmo, Faricimab, Diabetic Macular Edema, Poino maka mai ka maʻi diabetes, Lapaʻau maka, Diabetic Retinopathy, Aflibercept, Eylea, Nā inikini maka
⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

ʻAʻohe manaʻo i kau ʻia. Hoʻohui i kāu manaʻo ma ʻaneʻi no ka manawa mua.

Hoʻohui i kāu manaʻo

E ʻoluʻolu e helu: 3 + 9 =
Ua pilikia anei kou ʻike ma muli o ka maʻi diabetes? E kamaʻilio kākou e pili ana i ka lāʻau lapaʻau ʻo Vabysmo (Faricimab)

Ua pilikia anei kou ʻike ma muli o ka maʻi diabetes? E kamaʻilio kākou e pili ana i ka lāʻau lapaʻau ʻo Vabysmo (Faricimab)

Inā loaʻa iā ʻoe ka maʻi diabetes, ʻike paha ʻoe i ka hala ʻana o ka manawa, hiki ke hoʻopilikia i kou mau maka. ʻO ka ʻike maka pohihihi, nā mea lana, a me ka makapō kala nā hōʻailona maʻamau o kēia ʻano. Ua lohe paha ʻoe i nā inikini maka ma ke ʻano he lāʻau lapaʻau no kēia ʻano. Hiki i kēia mau inikini ke hoʻomaikaʻi i ka ʻike a hoʻōki i ka hōʻino hou ʻana i kou mau maka. I kēia lā, e kamaʻilio mākou e pili ana i kekahi lāʻau lapaʻau hou, kahi mea e kōkua nui iā ʻoe.

Pehea ka hana a kēia lāʻau Vabysmo no nā maka?

I ka ʻōlelo maʻalahi, ke loaʻa i kahi kanaka me ka maʻi diabetes ke kiʻekiʻe o ke kō koko no ka manawa lōʻihi, hoʻomaka ka hōʻino ʻia ʻana o nā kīʻaha koko palupalu i loko o ka maka. Hana ʻia kēia hōʻino ma ka retina, ka papa o ka maka e hana i nā kiʻi. Kāhea mākou i kēia ʻano he diabetic retinopathy .

Hoʻokahe mālie kēia mau kīʻaha koko i hōʻino ʻia i ke koko a me ka wai i loko o ka retina. I ka wā e ʻoi aʻe ai ke kūlana, hoʻāʻo ka maka e hana i nā kīʻaha koko hou e pani i nā mea i hōʻino ʻia. Akā, ua nāwaliwali loa kēia mau kīʻaha koko hou, a ʻoi aku ka nui o ka wai e kahe ana.

No laila he aha ka macular edema?

Aia kekahi wahi kūikawā ma ka retina i kapa ʻia ʻo ka macula . ʻO kēia ka mea e kōkua iā mākou e ʻike i nā mea i mua o ko mākou mau maka, ʻo ia hoʻi, ko mākou ʻike pololei, me ka maopopo. E like me ka mea i ʻōlelo ʻia ma mua, i ka wā e kahe ai ke wai mai nā kīʻaha koko, hoʻomaka kēia macula e pehu. Kāhea mākou i kēia he edema macular diabetic .

ʻO kēia ka manawa e pōwehiwehi ai ka ʻike, ʻike pālua ʻia ka ʻike, ʻike ʻia nā kiko ʻeleʻele, a ʻike ʻia nā kala me ka palalulu. Hiki i kekahi poʻe ke nalowale loa ko lākou ʻike.

He aha ka mea kūikawā e pili ana iā Vabysmo?

ʻO ka pahuhopu nui o ka mālama ʻana i kēia kūlana, ʻo ia ke kāohi i ka hōʻino ʻana i ka retina. Aia kekahi mau ʻano lāʻau lapaʻau i hoʻokomo ʻia i loko o ka maka no kēia. Hana ka hapa nui o kēia mau lāʻau lapaʻau ma ke kāohi ʻana i kahi protein i kapa ʻia ʻo VEGF . I ka ʻōlelo maʻalahi, ʻo VEGF kahi mea nui e kōkua ai i kēlā mau kīʻaha koko hou i makemake ʻole ʻia a nāwaliwali hoʻi e hana. No laila, ke ālai ʻia ʻo VEGF, ua kāohi ʻia ke kūkulu ʻia ʻana o nā kīʻaha koko hou.

ʻO Faricimab ka mea hana nui i loko o Vabysmo. ʻO kēia lāʻau lapaʻau, e like me nā lāʻau lapaʻau ʻē aʻe, ke ālai nei i ka VEGF. Akā ma waho aʻe o kēlā, hana kēia lāʻau lapaʻau i kahi mea ʻē aʻe. ʻO ia hoʻi, ke ālai nei ia i kahi protein ʻē aʻe i kapa ʻia ʻo Ang-2 (angiopoietin-2) . Ke hoʻonui ʻia kēia protein Ang-2 i loko o ka maka, lilo nā kīʻaha koko i mea paʻa ʻole a kahe hou aku ka wai.

No laila, no ka mea, ke ālai nei ʻo Vabysmo iā VEGF a me Ang-2 i ka manawa like, ke kāohi nei ia i ke kūkulu ʻia ʻana o nā kīʻaha koko hou a hoʻopaʻa i nā kīʻaha koko e kū nei, e hōʻemi ana i ka liki ʻana o ka wai. ʻO kēia hana pālua ka mea e kū hoʻokahi ai ʻo Vabysmo.

He aha ka mea i hōʻike ʻia e ka noiʻi ʻana e pili ana i kēia lāʻau lapaʻau?

Ua mālama ʻia ʻelua mau hoʻokolohua lapaʻau nui e hoʻoholo ai i ka palekana a me ka pono o Vabysmo, e pili ana i kahi heluna nui o ka poʻe me ka maʻi diabetes a me ka macular degeneration mai nā ʻāina a me nā lāhui like ʻole a puni ka honua.

Ma kēia mau hoʻokolohua, ua hoʻohālikelike ʻia ʻo Vabysmo me kahi lāʻau i loaʻa mua i kapa ʻia ʻo Aflibercept (Eylea) , ka mea e ālai wale ana i ka VEGF. ʻAʻole ʻike ka poʻe i komo i ka hoʻokolohua i ka lāʻau a lākou e loaʻa nei. Ua loaʻa i nā kānaka a pau kekahi mau inikini, akā ua emi iho ka nui o nā inikini i loaʻa i kekahi poʻe ma mua o nā poʻe ʻē aʻe.

He aha nā hopena o ka noiʻi?

He mea hoʻoikaika maoli nā hopena.

Ka hoʻomaikaʻi ʻana i ka ʻike maka

Ma hope o hoʻokahi makahiki o ka lāʻau lapaʻau, ua hoʻomaikaʻi nui ʻia ka ʻike o ka poʻe i lawe iā Vabysmo lāua ʻo Aflibercept ma mua o ka wā i hoʻomaka ai ke aʻo ʻana. ʻO ke ʻano kēia ua like ka maikaʻi o nā lāʻau ʻelua i ka hoʻomaikaʻi ʻana i ka ʻike .

Ka nui o nā inikini i koi ʻia (ʻo ia ka mea nui loa!)

ʻO kēia kahi i ʻike ʻia ai ka ʻokoʻa nui loa.

I nā mahina mua o ka noiʻi, ua hoʻopili ʻia nā kānaka a pau i hoʻokahi manawa i ka mahina, akā ua hoʻololi ʻia ka papa hana hoʻopili.

  • Ua hoʻomau ka poʻe i loaʻa iā Aflibercept i ka loaʻa ʻana o ka lāʻau pale i kēlā me kēia 8 pule (ʻo ia hoʻi, i kēlā me kēia 2 mahina) ma hope o nā mahina 5 mua.
  • Ua mālama ʻia ka poʻe i loaʻa iā Vabysmo e like me kahi "papa kuhikuhi dosis pilikino," ʻo ia hoʻi, ua loiloi ʻia ke kūlana o ka maka o kēlā me kēia kanaka a ua hāʻawi ʻia ka lāʻau pale i kēlā me kēia 4, 8, 12, a i ʻole 16 pule, e like me ke kūpono.

Ua hōʻike ʻia nā hopena he ʻoi aku ma mua o 70% o ka poʻe i loaʻa iā Vabysmo he pana wale nō i pono i kēlā me kēia 12-16 pule (ʻo ia hoʻi, i kēlā me kēia 3-4 mahina) . Eia kekahi, ʻaʻohe ʻokoʻa i ka hoʻomaikaʻi ʻana o ka maka ma waena o ka poʻe i loaʻa i ka lāʻau i kēlā me kēia 3-4 mahina a me ka poʻe i loaʻa i ka lāʻau i kēlā me kēia 2 mahina.

ʻO ke ʻano kēia, hiki i ka lāʻau lapaʻau ʻo Vabysmo ke hōʻemi nui i ka nui o nā kipa ʻana i ka haukapila no nā inikini , me ka mālama ʻana i ka hoʻomaikaʻi ʻana o ka ʻike. He mea maʻalahi loa ka hele ʻole ʻana i ka haukapila pinepine, ʻeā?

LapaʻauKa Wā Hoʻokomo Maʻamau
ʻO Vabysmo (Faricimab) 12 a 16 mau pule (i kēlā me kēia 3-4 mahina)
ʻAflibercept (Eylea) Hoʻokahi i kēlā me kēia 8 pule (hoʻokahi i kēlā me kēia 2 mahina)

E hoʻomau anei ka hana a ka lāʻau lapaʻau ma hope o ka makahiki mua?

ʻAe. Ua mālama ʻia kēia noiʻi ma luna o ʻelua mau makahiki. ʻO ka mea a lākou i ʻike ai, ma hope o ʻelua mau makahiki, ma kahi o 78% o ka poʻe i lawe iā Vabysmo e pono ai ka lāʻau lapaʻau i kēlā me kēia 3-4 mahina . A ua mau ko lākou ʻike e like me ia i ka makahiki mua.

Ma muli o ka holomua ʻana o ka pōʻino o ka maka mai ka maʻi diabetes i ka hala ʻana o ka manawa, hōʻike kēia mau hopena e hiki iā Vabysmo lāua ʻo Aflibercept ke kōkua i ka pale ʻana i ka pōʻino lōʻihi o ka maka. Hiki nō hoʻi iā Vabysmo ke hoʻokō i kēia hopena me nā lāʻau lapaʻau liʻiliʻi.

Pehea e loaʻa ai kēia lāʻau lapaʻau?

He wai ʻo Vabysmo. He inikini intravitreal ia i hāʻawi pololei ʻia i loko o ka maka e ke kauka i aʻo ʻia . ʻAʻole hiki iā ʻoe ke hana i kēia ma ka home.

Ke hoʻomaka ʻoe i ka lāʻau lapaʻau, e loaʻa mua iā ʻoe he 4 mau inikini i kēlā me kēia 4 pule . A laila e nānā kāu kauka i kou mau maka a hoʻoholo inā e hoʻomau i nā inikini ma nā manawa 4, 8, 12, a i ʻole 16 pule, ma muli o ke kūlana o kou mau maka. ʻO ka hapa nui o ka poʻe e pono ai nā inikini i kēlā me kēia 3-4 mahina.

I ka wā o ka inikini, e hoʻohana ke kauka i kahi mea liʻiliʻi e paʻa ai kou maka. A laila, e kau lākou i nā kulu i loko o kou maka e hoʻomāʻū iā ia a pale i ka maʻi. A laila, hāʻawi ʻia ka inikini me kahi nila lahilahi loa. ʻAʻole ʻoe e ʻeha i kēia manawa.

Nā hopena ʻaoʻao a pehea e mālama ai iā lākou?

E like me nā lāʻau lapaʻau āpau, hiki i kēia ke loaʻa nā hopena ʻaoʻao liʻiliʻi.

  • Nā hopena ʻaoʻao maʻamau: Hiki ke pohihihi kou ʻike no kekahi manawa pōkole ma hope o ka inikini. He mea maʻamau kēia. E pale i ka hoʻokele kaʻa a i ʻole ka hoʻohana ʻana i nā mīkini i kēia manawa. E hoʻi hou kou ʻike i ka maʻamau i ka manawa pōkole.
  • Nā hōʻailona koʻikoʻi e makaʻala ai: He mea kākaʻikahi loa, hiki ke loaʻa nā hōʻailona o kekahi mau maʻi koʻikoʻi. Pono ʻoe e makaʻala i kēia mau mea.
  • Me he mea lā e lana ana nā kiko ʻeleʻele a i ʻole nā ​​kaha i mua o nā maka.
  • Nā ʻālohilohi o ke kukui e like me ka uila .
  • Me he mea lā e huki ʻia ana kahi pale i mua o nā maka.
  • ʻEha nui o ka maka .

Inā ʻike ʻoe i kekahi o kēia mau hōʻailona, ​​mai hoʻokaʻulua . E ʻimi koke i ke kōkua lapaʻau. Inā hiki, e hele i ka ETU (Emergency Treatment Unit) o ​​ka haukapila no ka mālama ʻana. He mau hōʻailona paha kēia o kahi maʻi koʻikoʻi.

Aia kekahi pilikia me nā lāʻau lapaʻau ʻē aʻe?

ʻAʻohe pilina i ʻike ʻia ma waena o Vabysmo a me nā lāʻau lapaʻau ʻē aʻe i kēia manawa.

Akā, he mea nui loa kēia: E hōʻoia e haʻi i kāu kauka e pili ana i nā lāʻau lapaʻau ʻē aʻe āu e lawe nei, me nā lāʻau lapaʻau i kauoha ʻia, nā huaora, nā huahana lāʻau, a me nā lāʻau lapaʻau kuʻuna.

Leka Lawe-Home

  • He lāʻau pale hou ʻo Vabysmo, hana pālua ia e mālama ai i ka diabetic macular edema (DME).
  • Hoʻopale kēia i ʻelua mau protein (VEGF a me Ang-2) e kaohi ana i ke kūkulu ʻia ʻana o nā kīʻaha koko hou a me ke kahe ʻana o ka wai.
  • ʻAe kēia i nā poʻe he nui e hōʻemi i ke alapine (frequency) o nā lāʻau pale i kēlā me kēia 3-4 mahina me ka mālama ʻana i ka hoʻomaikaʻi like ʻana o ka maka.
  • He iniki kēia i hāʻawi ʻia i ka maka e ke kauka, a he mea nui loa ka loaʻa ʻana o ka lāʻau lapaʻau i ka manawa kūpono.
  • Inā loaʻa iā ʻoe ka ʻeha nui o ka maka, nā ʻālohilohi o ke kukui, a i ʻole ka uhi ʻana o kou maka e like me ka pale ma hope o ka loaʻa ʻana o ka lāʻau lapaʻau, e ʻimi koke i ke kōkua lapaʻau.
  • E kūkākūkā mau me kāu kauka maka i ke ʻano o ka lāʻau lapaʻau kūpono loa no kou kūlana.

Maʻi diabetes, ʻIke maka, Vabysmo, Faricimab, Diabetic Macular Edema, Poino maka mai ka maʻi diabetes, Lapaʻau maka, Diabetic Retinopathy, Aflibercept, Eylea, Nā inikini maka
⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

ʻAʻohe manaʻo i kau ʻia. Hoʻohui i kāu manaʻo ma ʻaneʻi no ka manawa mua.

Hoʻohui i kāu manaʻo

E ʻoluʻolu e helu: 3 + 9 =